Manning Meredith 4
4 · SOLENO THERAPEUTICS INC · Filed Mar 31, 2026
Research Summary
AI-generated summary of this filing
Soleno Therapeutics (SLNO) CCO Meredith Manning Sells Shares
What Happened Meredith Manning, Chief Commercial Officer of Soleno Therapeutics (SLNO), sold a total of 7,522 shares on March 27, 2026 for aggregate proceeds of approximately $228,980. The sales were reported as open-market/private sales and were executed to satisfy tax-withholding obligations in connection with vested restricted stock units (RSUs).
Key Details
- Transactions (all 2026-03-27):
- 4,864 shares at a weighted average price of $30.04 — proceeds $146,100 (multiple trades; prices ranged $29.54–$30.52).
- 2,100 shares at a weighted average price of $31.04 — proceeds $65,181 (multiple trades; prices ranged $30.545–$31.41).
- 558 shares at a weighted average price of $31.72 — proceeds $17,699 (multiple trades; prices ranged $31.64–$31.73).
- Total shares sold: 7,522; total proceeds: ~$228,980.
- Footnotes: Sales were to cover tax withholding for RSU vesting (F1). Some securities involved are RSUs (F3). Each sale was executed in multiple trades with price ranges and reported as weighted averages (F2, F4, F5).
- Shares owned after the transactions: not disclosed in this filing.
- Filing: Reported on 2026-03-31 — filed within the typical two-business-day Form 4 deadline for a 2026-03-27 transaction.
Context These sales were tax-withholding dispositions tied to RSU vesting (routine administrative transactions) rather than open-market purchases that might signal increased insider confidence. The filing shows sales (code "S") rather than purchases; for most retail investors, such withholding-related sales are considered routine and not necessarily indicative of the insider’s view on the company’s prospects.
Insider Transaction Report
- Sale
Common Stock
[F1][F2][F3]2026-03-27$30.04/sh−4,864$146,100→ 67,165 total - Sale
Common Stock
[F1][F4][F3]2026-03-27$31.04/sh−2,100$65,181→ 65,065 total - Sale
Common Stock
[F1][F5][F3]2026-03-27$31.72/sh−558$17,699→ 64,507 total
Footnotes (5)
- [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").
- [F2]This transaction was executed in multiple trades at prices ranging from $29.54 to $30.52. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
- [F4]This transaction was executed in multiple trades at prices ranging from $30.545 to $31.41. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F5]This transaction was executed in multiple trades at prices ranging from $31.64 to $31.73. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.